School of Medicine
Showing 1-8 of 8 Results
Brian A. Wandell
Isaac and Madeline Stein Family Professor and Professor, by courtesy, of Electrical Engineering, of Ophthalmology and at the Graduate School of Education
Current Research and Scholarly Interests Models and measures of the human visual system. The brain pathways essential for reading development. Diffusion tensor imaging, functional magnetic resonance imaging and computational modeling of visual perception and brain processes.
Assistant Professor of Ophthalmology
Current Research and Scholarly Interests Our research focuses on understanding the molecular mechanisms that underlie retinal diseases, e.g. diabetic retinopathy, and retinal development, via dissection of gene regulatory networks. We are interested in uncovering how different types of retinal cells, including retinal neurons, glia and the vasculature, respond to disease insults and developmental cues at the epigenomic and transcriptional levels, and how they interact with each other and collectively contribute to the integrity of the retina. We also develop novel methods and techniques that allow for rapid and efficient genetic manipulations in the retina in vivo in animal models.
Ira G. Wong, MD
Clinical Professor, Ophthalmology
Current Research and Scholarly Interests Investigation into immunomodulatory treatment of ocular inflammatory diseases.
Investigator, NIH sponsored Multi-centered Uveitis Steroid Treatment Trial.
Epidemiology of uveitis and ocular inflammatory diseases.
Albert Y. Wu, MD, PhD, FACS
Assistant Professor of Ophthalmology at the Stanford University Medical Center
Current Research and Scholarly Interests My translational research focuses on using autologous stem cells to recreate a patient’s ocular tissues for potential transplantation. We are generating tissue from induced pluripotent stem cells to treat limbal stem cell deficiency in patients who are bilaterally blind. By applying my background in molecular and cellular biology, stem cell biology, oculoplastic surgery, I hope to make regenerative medicine a reality for those suffering from orbital and ocular disease.